Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. (Q48110773)

8 February 2018

title

Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. (English)

1 reference

8 February 2018

0 references

C Ramassamy

1

1 reference

8 February 2018

D Averill

2

1 reference

8 February 2018

U Beffert

3

1 reference

8 February 2018

S Bastianetto

4

1 reference

8 February 2018

L Theroux

5

1 reference

8 February 2018

S Lussier-Cacan

6

1 reference

8 February 2018

J S Cohn

7

1 reference

8 February 2018

Y Christen

8

1 reference

8 February 2018

J Davignon

9

1 reference

8 February 2018

R Quirion

10

1 reference

8 February 2018

J Poirier

11

1 reference

8 February 2018

publication date

1 September 1999

1 reference

8 February 2018

Free Radical Biology and Medicine

published in

1 reference

8 February 2018

volume

27

1 reference

8 February 2018

issue

5-6

1 reference

8 February 2018

page(s)

544-553

1 reference

8 February 2018

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Evidence of an oxidative challenge in the Alzheimer's brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Oxidative damage in Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Free radical formation in autopsy samples of Alzheimer and control cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Protein measurement using bicinchoninic acid: elimination of interfering substances

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

1 reference

7 January 2021

Lipoprotein receptors and cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Association of transferrin C2 allele with late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in down's syndrome and Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

APOE genotyping and response to drug treatment in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900102-1

7 January 2021

10.1016/S0891-5849(99)00102-1

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10490274

1 reference

8 February 2018